In Europe, Sun Pharma has always had a focus on developing and offering hospital products in oncology and other areas.
Since the acquisition of Ranbaxy in 2015, a portfolio of retail products was added.
For the European hospital market, Sun aims to develop iv products that are convenient to use, such as Ready-to-Administer products in bags and syringes.
The first result of this initiative is launched in 2016.